홈 › 급성 골수성 백혈병 › 위스콘신 › Milwaukee
WI Milwaukee의 급성 골수성 백혈병 임상 시험
급성 골수성 백혈병 관련 연구 17개가 Milwaukee 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- 외 9개
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
피험자 모집 중관찰 연구
- Children's Hospital of Wisconsin, Milwaukee
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
피험자 모집 중2상
- Medical College of Wisconsin, Milwaukee
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
피험자 모집 중2상
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- 외 12개
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
피험자 모집 중2상
- Medical College of Wisconsin, Milwaukee
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
피험자 모집 중2상
- Medical College of Wisconsin, Milwaukee
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
피험자 모집 중2상
- Medical College of Wisconsin, Milwaukee
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
피험자 모집 중3상
- Children's Hospital of Wisconsin, Milwaukee
A Study of BGB-11417 in Participants With Myeloid Malignancies
피험자 모집 중1/2상
- Medical College of Wisconsin, Milwaukee
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
피험자 모집 중3상
- Froedtert & Medical College of Wisconsin, Milwaukee
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
피험자 모집 중1상
- Froedtert & Medical College Clinics, Milwaukee
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
피험자 모집 중1상
- Medical College of Wisconsin, Milwaukee
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
피험자 모집 중관찰 연구
- Children's Hospital of Wisconsin, Milwaukee
Ivosidenib as Post-HSCT Maintenance for AML
피험자 모집 중2상
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
피험자 모집 중2/3상
- Froedtert & Medical College of Wisconsin, Milwaukee
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
피험자 모집 중1상
- Medical College of Wisconsin Cancer Center, Milwaukee
Venetoclax to Augment Epigenetic Modification and Chemotherapy
피험자 모집 중1상
- Children's Wisconsin, Milwaukee
다른 도시의 급성 골수성 백혈병 시험
- Houston, TX연구 85개
- New York City, NY연구 51개
- Boston, MA연구 44개
- Baldwin Park, CA연구 40개
- Seattle, WA연구 40개
- Columbus, OH연구 35개
- Philadelphia, PA연구 34개
- Durham, NC연구 33개
- Atlanta, GA연구 30개
- Tampa, FL연구 29개
- Chicago, IL연구 26개
- Portland, OR연구 25개
Milwaukee의 다른 연구
- 유방암연구 23개
- 비소세포폐암연구 22개
- 암 (전체)연구 22개
- 폐암연구 21개
- 다발성 골수종연구 21개
- 전립선암연구 20개
- 여포성 림프종연구 19개
- 췌장암연구 18개
- 비호지킨 림프종연구 18개
- 난소암연구 17개
- 버킷 림프종연구 16개
- 심부전연구 16개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.